CD40LG and autoimmune polyendocrinopathy: Moderate or high IgM+ (aCL and/or aB2GPI) were found in 8 out of 51 patients (15.7%) who were classified as APS by ACR/EULAR compared with 17 out of the 18 not-classified (94.4%) (p < 0.001).